These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 35563887)

  • 1. Multifaceted and Intricate Oncogenic Mechanisms of NDRG1 in Head and Neck Cancer Depend on Its C-Terminal 3R-Motif.
    You GR; Chang JT; Li HF; Cheng AJ
    Cells; 2022 May; 11(9):. PubMed ID: 35563887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-myc downstream-regulated gene 1 downregulates cell proliferation, invasiveness, and tumorigenesis in human oral squamous cell carcinoma.
    Lee JC; Chung LC; Chen YJ; Feng TH; Juang HH
    Cancer Lett; 2014 Dec; 355(2):242-52. PubMed ID: 25218595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caffeic acid phenethyl ester upregulates N-myc downstream regulated gene 1 via ERK pathway to inhibit human oral cancer cell growth in vitro and in vivo.
    Chung LC; Chiang KC; Feng TH; Chang KS; Chuang ST; Chen YJ; Tsui KH; Lee JC; Juang HH
    Mol Nutr Food Res; 2017 Sep; 61(9):. PubMed ID: 28181403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MYH9 Facilitates Cell Invasion and Radioresistance in Head and Neck Cancer via Modulation of Cellular ROS Levels by Activating the MAPK-Nrf2-GCLC Pathway.
    You GR; Chang JT; Li YL; Huang CW; Tsai YL; Fan KH; Kang CJ; Huang SF; Chang PH; Cheng AJ
    Cells; 2022 Sep; 11(18):. PubMed ID: 36139430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of Aurora-A-FLJ10540 signaling axis prohibits the malignant state of head and neck cancer.
    Chen CH; Chang AY; Li SH; Tsai HT; Shiu LY; Su LJ; Wang WL; Chiu TJ; Luo SD; Huang TL; Chien CY
    Mol Cancer; 2015 Apr; 14():83. PubMed ID: 25889801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The metastasis suppressor, NDRG1, inhibits "stemness" of colorectal cancer via down-regulation of nuclear β-catenin and CD44.
    Wangpu X; Yang X; Zhao J; Lu J; Guan S; Lu J; Kovacevic Z; Liu W; Mi L; Jin R; Sun J; Yue F; Ma J; Lu A; Richardson DR; Wang L; Zheng M
    Oncotarget; 2015 Oct; 6(32):33893-911. PubMed ID: 26418878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microrchidia family CW‑type zinc finger 2 promotes the proliferation, invasion, migration and epithelial‑mesenchymal transition of glioma by regulating PTEN/PI3K/AKT signaling via binding to N‑myc downstream regulated gene 1 promoter.
    Zhang J; Yang Y; Dong Y; Liu C
    Int J Mol Med; 2022 Feb; 49(2):. PubMed ID: 34913078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-myc downstream-regulated gene 1/Cap43 may function as tumor suppressor in endometrial cancer.
    Lv XH; Chen JW; Zhao G; Feng ZZ; Yang DH; Sun WW; Fan JS; Zhu GH
    J Cancer Res Clin Oncol; 2012 Oct; 138(10):1703-15. PubMed ID: 22678098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two mechanisms involving the autophagic and proteasomal pathways process the metastasis suppressor protein, N-myc downstream regulated gene 1.
    Sahni S; Park KC; Kovacevic Z; Richardson DR
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1361-1378. PubMed ID: 30763642
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Interplays Between Cell Invasion and Radioresistance That Lead to Poor Prognosis in Head-Neck Cancer.
    You GR; Chang JT; Li YL; Chen YJ; Huang YC; Fan KH; Chen YC; Kang CJ; Cheng AJ
    Front Oncol; 2021; 11():681717. PubMed ID: 34307149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenic MNK signalling regulates the metastasis suppressor NDRG1.
    Tian S; Wang X; Proud CG
    Oncotarget; 2017 Jul; 8(28):46121-46135. PubMed ID: 28545025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Thiosemicarbazones Inhibit Lysine-Rich Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 (CEACAM1) Coisolated (LYRIC) and the LYRIC-Induced Epithelial-Mesenchymal Transition via Upregulation of N-Myc Downstream-Regulated Gene 1 (NDRG1).
    Xi R; Pun IH; Menezes SV; Fouani L; Kalinowski DS; Huang ML; Zhang X; Richardson DR; Kovacevic Z
    Mol Pharmacol; 2017 May; 91(5):499-517. PubMed ID: 28275050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological targeting and the diverse functions of the metastasis suppressor, NDRG1, in cancer.
    Park KC; Paluncic J; Kovacevic Z; Richardson DR
    Free Radic Biol Med; 2020 Sep; 157():154-175. PubMed ID: 31132412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NDRG1 as a biomarker for metastasis, recurrence and of poor prognosis in hepatocellular carcinoma.
    Cheng J; Xie HY; Xu X; Wu J; Wei X; Su R; Zhang W; Lv Z; Zheng S; Zhou L
    Cancer Lett; 2011 Nov; 310(1):35-45. PubMed ID: 21763068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic signature associated with radioresistance in head and neck cancer via transcriptomic and bioinformatic analyses.
    You GR; Cheng AJ; Lee LY; Huang YC; Liu H; Chen YJ; Chang JT
    BMC Cancer; 2019 Jan; 19(1):64. PubMed ID: 30642292
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the Metastasis Suppressor, N-Myc Downstream Regulated Gene-1, with Novel Di-2-Pyridylketone Thiosemicarbazones: Suppression of Tumor Cell Migration and Cell-Collagen Adhesion by Inhibiting Focal Adhesion Kinase/Paxillin Signaling.
    Wangpu X; Lu J; Xi R; Yue F; Sahni S; Park KC; Menezes S; Huang ML; Zheng M; Kovacevic Z; Richardson DR
    Mol Pharmacol; 2016 May; 89(5):521-40. PubMed ID: 26895766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NDRG1 in Aggressive Breast Cancer Progression and Brain Metastasis.
    Villodre ES; Hu X; Eckhardt BL; Larson R; Huo L; Yoon EC; Gong Y; Song J; Liu S; Ueno NT; Krishnamurthy S; Pusch S; Tripathy D; Woodward WA; Debeb BG
    J Natl Cancer Inst; 2022 Apr; 114(4):579-591. PubMed ID: 34893874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bidirectional Regulation between NDRG1 and GSK3β Controls Tumor Growth and Is Targeted by Differentiation Inducing Factor-1 in Glioblastoma.
    Ito H; Watari K; Shibata T; Miyamoto T; Murakami Y; Nakahara Y; Izumi H; Wakimoto H; Kuwano M; Abe T; Ono M
    Cancer Res; 2020 Jan; 80(2):234-248. PubMed ID: 31723002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The up-regulation of NDRG1 by HIF counteracts the cancer-promoting effect of HIF in VHL-deficient clear cell renal cell carcinoma.
    Zhang ZY; Zhang SL; Chen HL; Mao YQ; Li ZM; Kong CY; Han B; Zhang J; Chen YH; Xue W; Zhai W; Wang LS
    Cell Prolif; 2020 Jul; 53(7):e12853. PubMed ID: 32537867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The growth-inhibitory Ndrg1 gene is a Myc negative target in human neuroblastomas and other cell types with overexpressed N- or c-myc.
    Li J; Kretzner L
    Mol Cell Biochem; 2003 Aug; 250(1-2):91-105. PubMed ID: 12962147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.